er-positive breast cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Sanofi (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadESR1

I am/have/hadcancer metastatic

I am/have/hader-positive breast cancer

I am/have/hadadvanced breast cancer

I am/have/hadstage iv breast cancer

I am/have/hadbreast cancer

I am/have/hadestrogen receptor

I am/have/hadHER2

I am/have/hadlocally advanced breast cancer

I am/have/hadadenocarcinoma

I am/have/hadoestrogen receptor positive breast cancer

I am/have/hadcancer

I am/have/hadmetastasis

I am/have/hadtargeted therapy

I am/have/hadestrogen receptor-positive breast cancer

I am/have/hadestrogen

I am/have/hadestrogen receptor positive breast cancer

I am/have/hadadenocarcinoma of the breast

added new label for I am/have/had

more

I am looking for

I am looking forfulvestrant

I am looking forletrozole

I am looking foranastrozole

I am looking forendocrine therapy

I am looking forimmunological adjuvant

I am looking forestrogen

I am looking foradjuvant

I am looking forhormone therapy

I am looking forexemestane

I am looking fortamoxifen

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

ESR1

cancer metastatic

anastrozole

endocrine therapy

er-positive breast cancer

0 views
19 Feb, 2024
126 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.